[{"NetIncomeLoss_1_Q1_USD":-366000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3358000.0,"Liabilities_0_Q1_USD":55342000.0,"FinanceLeaseLiability_0_Q1_USD":4733000.0,"OperatingLeaseLiability_0_Q1_USD":4307000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":72000.0,"IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_1_Q1_USD":33000.0,"InventoryGross_0_Q1_USD":1036000.0,"DepreciationAndAmortization_1_Q1_USD":1065000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5042000.0,"RepaymentsOfLongTermDebt_1_Q1_USD":712000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":1599000.0,"InterestPaidNet_1_Q1_USD":256000.0,"InventoryFinishedGoods_0_Q1_USD":396000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-1474000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1155000.0,"FinanceLeaseInterestPaymentOnLiability_1_Q1_USD":69000.0,"AssetsCurrent_0_Q1_USD":15962000.0,"LongTermDebt_0_Q1_USD":24340000.0,"LongTermDebtCurrent_0_Q1_USD":6877000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":40000.0,"ContractWithCustomerLiability_0_Q1_USD":13635000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":12008000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":13000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":45000.0,"NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_1_Q1_USD":0.0,"FinanceLeaseInterestExpense_1_Q1_USD":69000.0,"InventoryValuationReserves_0_Q1_USD":160000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1063000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":138000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":4821000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1062000.0,"CommonStockSharesIssued_0_Q1_shares":11117999.0,"ProceedsFromLongTermLinesOfCredit_1_Q1_USD":387000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0041,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":731000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":196000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":4871000.0,"InventoryRawMaterials_0_Q1_USD":573000.0,"EarningsPerShareBasic_1_Q1_USD":-0.03,"FinanceLeasePrincipalPayments_1_Q1_USD":108000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":11016000.0,"PrepaidExpenseCurrent_0_Q1_USD":2546000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-1089000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":0.0,"AccountsReceivableNetCurrent_0_Q1_USD":8937000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.7656,"IncomeTaxExpenseBenefit_1_Q1_USD":33000.0,"CommonStockValue_0_Q1_USD":2741000.0,"OtherAssetsNoncurrent_0_Q1_USD":82000.0,"Revenues_1_Q1_USD":17885000.0,"ProceedsFromLinesOfCredit_1_Q1_USD":0.0,"ContractWithCustomerAssetNet_0_Q1_USD":2179000.0,"ForeignCurrencyTransactionGainLossUnrealized_1_Q1_USD":-9000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":-0.0989,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-429000.0,"UnamortizedDebtIssuanceExpense_0_Q1_USD":255000.0,"CommonStockNoParValue_0_Q1_USD":0.0,"ProceedsFromIssuanceOfDebt_1_Q1_USD":0.0,"FinanceLeaseLiabilityPaymentsDue_0_Q1_USD":4871000.0,"IncreaseDecreaseInInventories_1_Q1_USD":176000.0,"FairValueOfAssetsAcquired_1_Q1_USD":0.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":19000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-366000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":435000.0,"RepaymentsOfLinesOfCredit_1_Q1_USD":0.0,"LiabilitiesAssumed1_1_Q1_USD":0.0,"Assets_0_Q1_USD":62798000.0,"ShareBasedCompensation_1_Q1_USD":181000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0584,"Goodwill_0_Q1_USD":4368000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":181000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":1652000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":11016000.0,"InventoryWorkInProcess_0_Q1_USD":67000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":1029000.0,"LiabilitiesCurrent_0_Q1_USD":34561000.0,"AccountsPayableCurrent_0_Q1_USD":3630000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":40000.0,"InterestExpense_1_Q1_USD":347000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":44000.0,"LongTermDebtNoncurrent_0_Q1_USD":17208000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":13000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.03,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"FinanceLeaseRightOfUseAssetAmortization_1_Q1_USD":37000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0522,"SubleaseIncome_1_Q1_USD":160000.0,"LiabilityForUncertainTaxPositionsCurrent_0_Q1_USD":0.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":5000.0,"ShortTermLeaseCost_1_Q1_USD":10000.0,"StockIssued1_1_Q1_USD":0.0,"AdditionalPaidInCapital_0_Q1_USD":26966000.0,"OtherIntangibleAssetsNet_0_Q1_USD":4104000.0,"RestructuringReserveCurrent_0_Q1_USD":178000.0,"OperatingLeasePayments_1_Q1_USD":229000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":175000.0,"PaymentsForProceedsFromProductiveAssets_1_Q1_USD":1474000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":29316000.0,"GrossProfit_1_Q1_USD":5877000.0,"VariableLeasePayment_1_Q1_USD":76000.0,"CommonStockSharesOutstanding_0_Q1_shares":11117999.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":634000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":4093000.0,"PaymentsToAcquireBusinessesGross_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":3.41,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":564000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":609000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":231000.0,"CommonStockSharesAuthorized_0_Q1_shares":19000000.0,"OperatingIncomeLoss_1_Q1_USD":14000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q1_shares":700.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-333000.0,"InventoryNet_0_Q1_USD":876000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"PreferredStockValue_0_Q1_USD":25000.0,"OperatingLeaseCost_1_Q1_USD":229000.0,"SellingExpense_1_Q1_USD":625000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":62798000.0,"FinanceLeaseRightOfUseAsset_0_Q1_USD":4742000.0,"ProceedsFromConstructionLoansPayable_1_Q1_USD":0.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":949000.0,"OperatingExpenses_1_Q1_USD":5863000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":448000.0,"ProfitLoss_1_Q1_USD":-366000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":4693000.0,"StockholdersEquity_0_Q1_USD":7456000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":561000.0,"LeaseIncentiveReceivableNoncurrent_0_Q1_USD":131000.0,"VariableLeaseCost_1_Q1_USD":2000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-22276000.0,"LeaseCost_1_Q1_USD":187000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-251000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":181000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":2242000.0,"Ticker":"NOTV","CIK":"720154","name":"BIOANALYTICAL SYSTEMS INC","OfficialName":"Inotiv Inc. Common Stock","form":"10-Q","period":"20201231","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"611279258.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210210"}]